Interestingly, patients with congenital FXI deficiency carry a lower risk for venous thromboembolism (VTE) and ischaemic stroke, whereas high plasma FXI levels have been reported to be associated with an increased risk of both venous and arterial thrombotic complications. This evidence concerns the gene F11 and venous thromboembolism.